GELSOMINO, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 4.602
AS - Asia 2.196
EU - Europa 2.171
SA - Sud America 307
Continente sconosciuto - Info sul continente non disponibili 90
AF - Africa 56
OC - Oceania 5
Totale 9.427
Nazione #
US - Stati Uniti d'America 4.475
IT - Italia 739
SG - Singapore 667
CN - Cina 595
GB - Regno Unito 391
VN - Vietnam 248
HK - Hong Kong 239
BR - Brasile 222
FI - Finlandia 171
SE - Svezia 159
DE - Germania 150
FR - Francia 114
RU - Federazione Russa 113
BD - Bangladesh 97
UA - Ucraina 73
CA - Canada 66
IE - Irlanda 64
IN - India 61
KR - Corea 59
ID - Indonesia 56
MX - Messico 36
TR - Turchia 36
AR - Argentina 32
LT - Lituania 30
JP - Giappone 27
BG - Bulgaria 26
ZA - Sudafrica 24
ES - Italia 22
AT - Austria 20
NL - Olanda 20
PL - Polonia 20
IQ - Iraq 16
EC - Ecuador 14
VE - Venezuela 13
CZ - Repubblica Ceca 12
AE - Emirati Arabi Uniti 11
BE - Belgio 11
PK - Pakistan 10
UZ - Uzbekistan 10
CH - Svizzera 9
JM - Giamaica 8
PY - Paraguay 8
AZ - Azerbaigian 7
JO - Giordania 7
TN - Tunisia 7
CO - Colombia 6
MY - Malesia 6
NP - Nepal 6
AU - Australia 5
EU - Europa 5
KE - Kenya 5
PH - Filippine 5
CL - Cile 4
DK - Danimarca 4
EG - Egitto 4
IR - Iran 4
MA - Marocco 4
PE - Perù 4
RO - Romania 4
AL - Albania 3
CY - Cipro 3
HU - Ungheria 3
IL - Israele 3
KZ - Kazakistan 3
NG - Nigeria 3
PA - Panama 3
PT - Portogallo 3
UG - Uganda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
KH - Cambogia 2
LB - Libano 2
NO - Norvegia 2
OM - Oman 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AN - Antille olandesi 1
BB - Barbados 1
BM - Bermuda 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
GT - Guatemala 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
Totale 9.335
Città #
Ashburn 592
Santa Clara 441
Singapore 407
Fairfield 395
San Jose 262
Chandler 254
Hong Kong 234
Woodbridge 196
Southend 182
Hefei 160
Council Bluffs 154
Seattle 152
Helsinki 149
Houston 148
Wilmington 133
Cambridge 128
Nyköping 116
London 97
New York 97
Beijing 92
Los Angeles 85
Ho Chi Minh City 83
Shanghai 79
Dearborn 73
Ann Arbor 71
Dublin 61
Seoul 58
Hanoi 50
Milan 48
Jacksonville 47
Modena 47
Chicago 46
San Diego 46
Jakarta 45
Lauterbourg 36
The Dalles 32
Munich 30
Buffalo 28
Rome 28
Princeton 27
Boardman 26
Dong Ket 26
Orem 26
Bologna 25
Moscow 25
Sofia 25
São Paulo 24
Tokyo 24
Atlanta 23
Dallas 22
Izmir 21
Salt Lake City 20
Florence 19
Phoenix 19
Bremen 18
Johannesburg 18
Eugene 16
Ottawa 16
Warsaw 16
Brooklyn 15
Columbus 14
Montreal 14
Toronto 14
Falls Church 13
Frankfurt am Main 13
Naples 13
Poplar 13
Siena 13
Turku 13
Mexico City 12
Reggio Emilia 12
Stockholm 12
Denver 11
Ferrara 11
Kent 11
Manchester 11
Redwood City 11
Brussels 10
Des Moines 10
Parma 10
Redondo Beach 10
Boston 9
Brno 9
Düsseldorf 9
Hyderabad 9
Nuremberg 9
Vienna 9
Washington 9
Baghdad 8
Charlotte 8
Chennai 8
Guangzhou 8
Haiphong 8
Philadelphia 8
Tampa 8
Amsterdam 7
Brasília 7
Da Nang 7
Elk Grove Village 7
Mumbai 7
Totale 6.238
Nome #
Mutazioni somatiche di BRAF in pazienti affetti da melanoma maligno metastatico ed efficacia clinica degli approcci terapeutici a bersaglio molecolare con inibitori di BRAF 624
A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study) 450
The evolving role of microsatellite instability in colorectal cancer: A review 362
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study 356
Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion 349
BRAFp.V600E, p.V600K, and p.V600R Mutations in Malignant Melanoma: Do They Also Differ in Immunohistochemical Assessment and Clinical Features? 327
Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanomas 319
Il trattamento di prima e seconda linea nel carcinoma gastrico 318
Multicentre validation of an immune-inflammation-based nomogram to predict survival in western resectable gastroesophageal adenocarcinoma: The NOMOGAST 291
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer 284
The perception of health-related quality of life in colon cancer patients during chemotherapy: differences between men and women 280
Impact of second-line cetuximab-containing therapy in patients with KRAS wild-type metastatic colorectal cancer: Results from the ITACa randomized clinical trial 280
Class 1, 2, and 3 BRAF-mutated metastatic colorectal cancer: A detailed clinical, pathologic, and molecular characterization 266
Immune-inflammatory and clinicopathologic prognostic factors in a Western cohort of resected gastric cancers (GCs) 259
Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial 253
Erratum: Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanoma (Disease Markers) 250
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study 246
A user-friendly nomogram to predict relapse-free survival (RFS) in western patients with resected gastric cancer (GC) 244
Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study 241
Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experience. 239
BRAF-mutated colorectal cancer: Clinical and molecular insights 239
The growing skyline of advanced hepatocellular carcinoma treatment: A review. 230
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy 229
The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center 224
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice 219
Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGAST 213
Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study 202
Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters 187
Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma 182
Hereditary Micro‑Satellite Instable cancers associated with Lynch Syndrome: predictive biomarkers and novel immuno-therapeutic approaches 178
The Role of Anti-Angiogenics in Pre-Treated Metastatic BRAF-Mutant Colorectal Cancer: A Pooled Analysis 150
Early Onset Metastatic Colorectal Cancer: Current Insights and Clinical Management of a Rising Condition 149
mTOR Pathway Expression as Potential Predictive Biomarker in Patients with Advanced Neuroendocrine Tumors Treated with Everolimus 146
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy 142
Homologous recombination deficiency in pancreatic neuroendocrine tumors 137
Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience 132
Spontaneous Regression of an Inflammatory Myofibroblastic Tumor: A Case Report and a Review of the Literature 108
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study 104
Preparing real-world data through common data model harmonization of cancer patient records in the COMNet platform at the Modena Oncology Center. 18
Totale 9.427
Categoria #
all - tutte 36.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022540 0 0 30 19 32 57 18 43 60 88 137 56
2022/2023723 80 94 55 76 82 95 13 56 103 22 27 20
2023/2024499 7 26 36 70 66 54 52 61 5 10 54 58
2024/20251.674 56 15 27 108 288 232 144 103 198 91 134 278
2025/20263.493 272 126 216 395 513 238 465 190 282 353 283 160
2026/2027305 107 191 7 0 0 0 0 0 0 0 0 0
Totale 9.427